Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
Sales | 864,500 | 894,874 | 904,015 | 876,103 | 768,767 |
Cost of Goods | 373,303 | 390,556 | 397,726 | 385,405 | 321,509 |
Gross Profit | 491,197 | 504,318 | 506,289 | 490,698 | 447,258 |
Operating Expenses | 257,235 | 256,163 | 245,102 | 249,463 | 224,341 |
Operating Income | 234,265 | 248,711 | 261,913 | 241,640 | 223,426 |
Interest Expense | 5,462 | 5,948 | 5,360 | 5,287 | 5,823 |
Other Income | -2,484 | -5,477 | 2,235 | 2,858 | 402 |
Pre-tax Income | 226,319 | 237,286 | 258,788 | 239,211 | 218,005 |
Income Tax | 47,307 | 35,535 | 55,175 | 44,111 | 296,486 |
Net Income Continuous | 179,012 | 201,751 | 203,613 | 195,100 | -78,481 |
Net Income | $179,012 | $201,751 | $203,613 | $195,100 | $-78,481 |
EPS Basic Total Ops | 1.22 | 1.38 | 1.40 | 1.34 | -0.54 |
EPS Basic Continuous Ops | 1.22 | 1.38 | 1.40 | 1.34 | -0.54 |
EPS Diluted Total Ops | 1.22 | 1.37 | 1.39 | 1.33 | -0.54 |
EPS Diluted Continuous Ops | 1.22 | 1.37 | 1.39 | 1.33 | -0.54 |
EBITDA(a) | $285,874 | $298,317 | $309,532 | $287,319 | $271,308 |